Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge

Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ transplant recipients were not included in the original clinical trials of these agents, so studies of real-world outcomes...

Descripción completa

Detalles Bibliográficos
Autor principal: Avery, Robin Kimiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311293/
https://www.ncbi.nlm.nih.gov/pubmed/35700481
http://dx.doi.org/10.1097/TP.0000000000004200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311293/
https://www.ncbi.nlm.nih.gov/pubmed/35700481
http://dx.doi.org/10.1097/TP.0000000000004200

Ejemplares similares